Fieldfisher > Frankfurt am Main, Germany > Firm Profile
Fieldfisher Offices

Turmcenter
Eschersheimer Landstraße 14
60322
Germany
- Go to...
- Rankings
- Firm Profile
- Comparative Guides
Fieldfisher > The Legal 500 Rankings
Industry focus > Healthcare and life sciences Tier 3
Fieldfisher convinces with its internationally oriented healthcare, pharmaceuticals and life sciences group in Germany, France, Belgium and Great Britain. The German partner trio consists of Cord Willhöft (market access, reimbursement, compliance for medical device and pharmaceutical manufacturers), Stefanie Greifeneder (commercial IP), both in Munich, and Michael Adam in Hamburg, who specialises in corporate and antitrust law in the life sciences sector.Practice head(s):
Testimonials
‘The Fieldfisher team is always at our side with pragmatic advice. Fieldfisher understands how to give legal advice in the form and language that the client desires. Cord Willhöft is pragmatic, experienced and proactive. ‘
‘Very experienced team, especially in the field of medical device law, both in terms of regulation and with regard to market access. Cord Willhöft has an excellent understanding of the needs of his clients, be they individual companies or associations.’
Key clients
Advanced Bionics GmbH und Advanced Bionics AG
Amisar Munich Biohealth GmbH
Asahi Kasei Medical Co Ltd
Axonics Ltd.
Gala Therapeutics
Intersect ENT Inc
Kawasaki Robotics
Nuvaira
Procept BioRobotics
Pulmonx Sarl und Pulmonx Co.
ResMed GmbH & Co KG
Retina Implant AG
Saluda Medical
ZOLL CMS GmbH und ZOLL Medical Corporation
Olympus/KeyMed Gruppe
Germany > Antitrust Tier 6
Fieldfisher's expertise spans various areas of competition and antitrust law, with a focus on antitrust investigations, competition litigation and competition compliance. The team is jointly led by a trio in Düsseldorf and Hamburg: Christian Bahr, who advises a federal ministry on antitrust law; Michael Adam, who has expertise in cross-border transactions; and Sascha Dethof, who has many years of experience in antitrust investigations and damages claims.Practice head(s):
Key clients
BMWi
Bombardier Aerospace
Deutsches Obstsorten Konsortium
Edding
Sonova
Work highlights
- Antitrust advice to BMWi (Federal Ministry for Economic Affairs and Energy) on the founding process of the European cloud infrastructure GAIA-X.
- Comprehensive advice to Sonova on the acquisition of Sennheiser Consumer Division.
Fieldfisher > Firm Profile
Fieldfisher is a European law firm with market leading practices in many of the world’s most dynamic sectors
We are a forward-thinking organization with a sector focus on Technology, Life Sciences, Energy and Finance & Financial Services. As a marker of the firm’s truly international presence, and focus on the Technology sector, Fieldfisher also opened in Silicon Valley in 2012. China followed in 2016, where we now have offices in Beijing, Shanghai and Guangzhou. We now have 25 offices worldwide. As a firm with a strong technology focus, we also use technology and innovation to drive cost and time efficiencies. We use new models of working and staff teams appropriately, integrating legal technology and new skill sets needed for today’s modern legal adviser. Clients choose to work with us because we deliver commercial, pragmatic and innovative solutions through our exceptional legal expertise and experience, on time and on budget. When asked, clients say we are friendly and down to earth.
We are a law firm built around people with all their diversity and we strike a healthy balance between legal excellence and a down-to-earth practical approach to our clients’ needs. We believe The Future is Human, so we choose a collaborative approach with an intense focus on the end-user and consider carefully how to shape our services to add the most value to our clients.
Our Frankfurt team specializes in Finance Regulation with a particular emphasis on digital business models. We further advise on Corporate/M&A, Compliance and Tax law. Many of our clients are financial institutions, Fintechs, and global banks settling in Frankfurt in the course of Brexit.
- Industry focus > Healthcare and life sciences